[1]施巍,苟小军,王道才,等.刺络放血法治疗慢性阻塞性肺疾病急性加重期48例[J].西部中医药,2017,30(02):96-97.
　SHI Wei,GOU Xiaojun,WANG Daocai,et al.Blood-letting Therapy in Treating 48 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation Stage[J].Western Journal of Traditional Chinese Medicine,2017,30(02):96-97.
点击复制

刺络放血法治疗慢性阻塞性肺疾病急性加重期48例()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
30
期数:
2017年02期
页码:
96-97
栏目:
出版日期:
2017-02-15

文章信息/Info

Title:
Blood-letting Therapy in Treating 48 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation Stage
文章编号:
1004-6852(2017)02-0096-02
作者:
施巍，苟小军，王道才，李达，张连东△
上海市宝山区中西医结合医院，上海 201999
Author(s):
SHI Wei, GOU Xiaojun, WANG Daocai, LI Da, ZHANG Liandong△
Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai, Shanghai 201999, China
关键词:
慢性阻塞性肺疾病; 急性加重期; 膻中; 天突; 针刺放血
Keywords:
COPD;  acute exacerbation stage;  TanZhong(RN17);  TianTu (RN22) ;  blood-letting
分类号:
R563
文献标志码:
B
摘要:
目的：观察膻中及天突穴针刺放血治疗慢性阻塞性肺疾病急性加重期(AECOPD)患者的临床疗效。方法：将94例患者随机分为观察组48例、对照组46例。2组均给予常规西医治疗，观察组同时给予膻中、天突针刺放血治疗，2组均连续治疗14天。观察临床疗效及治疗前后肺功能变化情况。结果：总有效率观察组为91.7%，对照组为78.3%，2组比较差异有统计学意义(P＜0.05)。第1秒用力呼气容积占预计值百分比(FEV1%)、第1秒用力呼气容积与用力肺活量比值(FEV1／FVC)治疗前后2组组内比较，差异均有统计学意义(P＜0.05)，治疗后组间比较差异也有统计学意义(P＜0.05)。结论：常规西医治疗基础上给予膻中、天突针刺放血能显著改善AECOPD患者肺功能，并能提高临床疗效。
Abstract:
Objective: To observe the clinical effects of blood-letting at TanZhong(RN17) and TianTu (RN22) in treating acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Methods: 94 patients were randomly divided into the observation group(48 cases) and the control group(46 cases). Both groups were given routine Western medicine treatment, the observation group was given blood-letting at RN17 and RN22, both groups given continuous treatment for 14 days. The clinical effects and the changes of lung function were observed before and after treatment. Results: The total effective rate in the observation group was 91.7%, the control group was 78.3%, there was statistical difference between two groups(P＜0.05). Compared the first second of FEV1% and FEV1/FVC within two groups before and after treatment, there were statistical differences(P＜0.05), there were statistical differences betweeen two groups after treatment(P＜0.05). Conclusion: Routine Western medicine with blood-letting at RN17 and RN22 can improve the lung function of AECOPD significantly, and promote clinical effects.

相似文献/References:

[1]李英梅,刘莉.中医护理对慢性阻塞性肺疾病急性加重期患者的干预效果研究[J].西部中医药,2014,27(10):148.
[2]王萍.慢性阻塞性肺病患者实施临床护理路径的疗效分析[J].西部中医药,2014,27(11):140.
[3]王 燕,孙凤英,倪 军.慢性阻塞性肺疾病患者非药物治疗依从性与生活质量相关性的研究[J].西部中医药,2015,28(03):89.
[4]郭晓燕,尹广超,陆城华,等.川芎平喘合剂对COPD患者血管内皮功能的调节作用[J].西部中医药,2015,28(05):1.
[5]王振伟,杨佩兰,沈丽,等.百部养肺煎膏治疗COPD稳定期患者的临床研究[J].西部中医药,2015,28(05):56.
[6]赵宇冰,林丽明.老年慢性阻塞性肺疾病患者缓解期的社区康复治疗[J].西部中医药,2012,25(08):59.
　ZHAO Yu-bing,LIN Li-ming.Community Rehabilitation Therapy for Senile Patients with COPD at Remission Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(02):59.
[7]张旭辉,杨虹.咳喘宁胶囊治疗稳定期慢性阻塞性肺疾病的疗效评价[J].西部中医药,2016,29(03):1.
　ZHANG Xuhui,YANG Hong.Evaluation of Clinical Effects of KeChuanNing Capsules in Treating Chronic Obstructive Pulmonary Disease at Stable Stage[J].Western Journal of Traditional Chinese Medicine,2016,29(02):1.
[8]郭晓燕,腾飞,张惠勇.川芎平喘合剂治疗慢性阻塞性肺疾病的随机对照研究[J].西部中医药,2018,31(01):1.
　GUO Xiaoyan,TENG Fei,ZHANG Huiyong.A Randomized, Controlled Study of ChuanXiong PingChuan Mixture in Treating Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(02):1.
[9]史素丽,尚秀娟△,曹凤英.老年慢性阻塞性肺疾病患者主观幸福度及影响因素分析[J].西部中医药,2016,29(01):93.
　SHI Suli,SHANG Xiujuan,CAO Fengying.Analysis of Influencing Factors and Subjective Happiness Index of Senile Patients with Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2016,29(02):93.
[10]韩敏娟,曹鹏鹏,胡建明,等.慢性阻塞性肺疾病不同表型与中医证型的相关性研究[J].西部中医药,2016,29(03):63.
　HAN Minjuan,CAO Pengpeng,HU Jianming,et al.Correlation Study between Clinical Phenotypes of Chronic Obstructive Pulmonary Disease and TCM Patterns[J].Western Journal of Traditional Chinese Medicine,2016,29(02):63.
[11]晏燕,孙建勤,姜冰玉,等.中西医结合治疗老年慢性阻塞性肺疾病急性加重期的临床疗效[J].西部中医药,2016,29(07):96.
　YAN Yan,SUN Jianqin,JIANG Bingyu,et al.Clinical Effects of Integrative Medicine in Treating Chronic Obstructive Pulmonary Disease of Senile Patients at Acute Exacerbation[J].Western Journal of Traditional Chinese Medicine,2016,29(02):96.
[12]王玉湘,余锡兰,刘巧云,等.穴位贴敷结合基于体质辨识的健康指导对AECOPD患者临床症状、住院时间和肺功能的影响[J].西部中医药,2022,35(06):124.[doi:10.12174/j.issn.2096-9600.2022.06.31]
　WANG Yuxiang,YU Xilan,LIU Qiaoyun,et al.Influence of Acupoint Application Combined with Health Guidance Based on Physical Identification on Clinical Symptoms, Hospital Stay and Pulmonary Function in AECOPD Patients[J].Western Journal of Traditional Chinese Medicine,2022,35(02):124.[doi:10.12174/j.issn.2096-9600.2022.06.31]

备注/Memo

备注/Memo:
收稿日期：2016-11-26*基金项目：宝山区科技创新专项基金项目(编号13-E-16)；上海市进一步加快中医药事业发展三年行动计划(2014—2016年)资助课题(编号ZY3-RCPY-3-1013)。作者简介：施巍(1980—)，男，主治医师。研究方向：急症医学。△通讯作者：张连东(1956—)，男，副主任医师。研究方向：急症医学。
更新日期/Last Update: 2017-02-15